Theranos Deception
Elizabeth's claims about a revolutionary blood testing device raised significant questions about transparency and scientific validity. Despite the allure of rapid wealth during the unicorn boom, investors overlooked critical evidence, swayed by her charisma and the promise of groundbreaking technology. The conversation highlights the dangers of unchecked optimism in the tech world and the consequences of believing in a compelling narrative without scrutiny.In this clip
From this podcast
Decoder with Nilay Patel
John Carreyrou’s final chapter on the Theranos scandal
Related Questions